SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.79-0.3%Nov 13 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (7015)2/15/1999 11:10:00 PM
From: Brander  Read Replies (1) of 9523
 
J Clin Psychiatry 60:1, Jan 1999

Title: Sildenafil for Iatrogenic Serotonergic Antidepressant Medication-Induced Sexual Dysfunction in 4 Patients

Objective: To evaluate the effect of sildenafil on iatrogenic serotonergic antidepressant-induced sexual dysfunction.

Results: Four cases (2 men, 2 women) are detailed in case report fashion. All 4 had rapid reversal of their sexual dysfunction, usually with the first dose. Reversal equates to 1 successful use of sildenafil in each of 2 patients and 3 uses in 2 patients.

Conclusion: Sildenafil may be an effective treatment for serotonergic antidepressant-induced sexual dysfunction and deserves further evaluation in randomized placebo-controlled studies.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext